XTX Topco Ltd Has $280,000 Position in Indivior PLC (NASDAQ:INDV)

XTX Topco Ltd lessened its holdings in shares of Indivior PLC (NASDAQ:INDV - Free Report) by 83.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 22,531 shares of the company's stock after selling 110,663 shares during the period. XTX Topco Ltd's holdings in Indivior were worth $280,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of the business. Mirae Asset Global Investments Co. Ltd. acquired a new position in Indivior during the 4th quarter worth about $56,000. Stifel Financial Corp bought a new position in shares of Indivior during the third quarter worth about $100,000. Jane Street Group LLC acquired a new position in shares of Indivior in the third quarter worth approximately $180,000. Rathbones Group PLC boosted its holdings in Indivior by 11.6% in the fourth quarter. Rathbones Group PLC now owns 14,284 shares of the company's stock valued at $183,000 after acquiring an additional 1,483 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. acquired a new stake in Indivior during the 4th quarter valued at approximately $359,000. Institutional investors own 60.33% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on the stock. Piper Sandler dropped their price target on shares of Indivior from $16.00 to $13.00 and set an "overweight" rating on the stock in a research report on Thursday, March 6th. RODMAN&RENSHAW raised shares of Indivior to a "strong-buy" rating in a research report on Tuesday, January 28th. Finally, Rodman & Renshaw started coverage on Indivior in a research report on Tuesday, January 28th. They issued a "buy" rating and a $16.00 price objective for the company.

Indivior Price Performance

Shares of NASDAQ:INDV traded up $0.31 during mid-day trading on Thursday, hitting $11.82. The company had a trading volume of 145,407 shares, compared to its average volume of 973,743. Indivior PLC has a one year low of $7.33 and a one year high of $18.59. The firm has a fifty day moving average price of $9.61 and a 200 day moving average price of $10.38. The company has a market capitalization of $1.63 billion, a PE ratio of -33.84 and a beta of 0.93.

Indivior (NASDAQ:INDV - Get Free Report) last posted its quarterly earnings results on Thursday, April 24th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.22 by $0.19. The firm had revenue of $266.00 million during the quarter, compared to the consensus estimate of $240.13 million. Indivior had a negative net margin of 3.96% and a negative return on equity of 241.73%. Research analysts expect that Indivior PLC will post 1.22 earnings per share for the current fiscal year.

Indivior Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.